Glenn Rosen
Academic Appointments
- Associate Professor, Medicine - Pulmonary & Critical Care Medicine
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Pulmonary & Critical Care Clinic 300 Pasteur Dr A265 MC 5319 Stanford, CA 94305 Tel Work (650) 725-7061 Fax (650) 498-6288
- Academic Offices
Alternate Contact Latoya King Administrative Associate Email Tel Work 650-721-3068Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pulmonology (Lung) and Critical Care
- Pulmonary Disease
Administrative Appointments
- Director, Fellowship Program, Pulmonary and Critical Care Medicine (2004 - present)
- Division Co-Chief, Pulmonary and Critical Care Medicine (2004 - present)
Honors and Awards
- Award for Lung Cancer Research, Jack Elway Memorial Fund (2002-2003)
- Institutional American Cancer Society Award, Stanford University (1994-1995)
- Research Fellowship Award, American Lung Association (1990)
- Magna Cum Laude, University of Pennsylvania (1979)
- Phi Betta Kappa, University of Pennsylvania (1979)
Professional Education
| Residency: | Graduate Hospital PA (1986) |
| Board Certification: | Pulmonary Disease, American Board of Internal Medicine (1990) |
| Medical Education: | University of Pennsylvania PA (1983) |
| Fellowship: | Washington Univiversity Medical Center MO (1992) |
| Fellowship: | UCSF Medical Center CA (1987) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
Graduate & Fellowship Program Affiliations
Community and International Work
Internet Links
Scientific Focus
Current Research Interests
Our laboratory examines apoptotic and cell cycle pathways in the lung with a focus on fibrotic lung disease and lung cancer. We have identified a novel regulator of cell cycle progression in immune cells. We are also studying TGF beta signaling in lung cells which regulates myofibroblast differentiation and epithelia mesenchymal transition. Our laboratory is also collaborating with the laboratory of Dr. Irving Weissman to isolate and characterize lung cancer stem cells, and we are collaborating with a local biotechnology company on a proteomic analysis of lung cancer. We also are involved in trials of novel therapeutics for patients with pulmonary fibrosis.
Publications
- An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. J Rheumatol. 2011; (4): 693-701
- SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J Biol Chem. 2010; (11): 8196-206
- Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009; (2): 135-46
- Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium. FEBS Lett. 2008; (25-26): 3601-6
- Ambient particulate matter induces alveolar epithelial cell cycle arrest: role of G1 cyclins. FEBS Lett. 2007; (27): 5315-20
- Bim mediates mitochondria-regulated particulate matter-induced apoptosis in alveolar epithelial cells. FEBS Lett. 2007; (22): 4148-52
Help